Nagi Mohammed a , Adam Buckley a , Mohsin Siddiqui a , Sameera Al Ahmed a , Bachar Afandi b , Mohamed Hassanein c , Nader Lessan a , Mohamed Suliman
doi : 10.1016/j.dsx.2023.102754
Volume 17, Issue 4, April 2023, 102754
A new IDF-DAR (International Diabetes Federation - Diabetes and Ramadan Alliance) risk stratification tool was published in 2021 to better stratify the risk of Ramadan fasting in people with diabetes.
Akrem Elmalti a , Mamoun Mukhtar a , Sami Kenz a , Sijomol Skaria a , Targ Elgzyri
doi : 10.1016/j.dsx.2023.102745
Volume 17, Issue 4, April 2023, 102745
We aimed to examine the effect of Ramadan fasting on interstitial glucose control and variability before, during, and after Ramadan in type 2 diabetes patients receiving insulin therapy.
Baani Sodhi a , Mansi Malik a , Paras Agarwal b , Saurav Basu
doi : 10.1016/j.dsx.2023.102745
Volume 17, Issue 4, April 2023, 102745
Sihyung Lee a , Duk Chul Lee a , Hye Jun Lee
doi : 10.1016/j.dsx.2023.102763
Volume 17, Issue 4, April 2023, 102763
This study aimed to investigate the association between breakfast frequency and insulin resistance using the triglyceride and glucose (TyG) index in Korean adults with prediabetes.
Raju Vaishya a, *, Anoop Misra b , Abhishek Vaish
doi : 10.1016/j.dsx.2023.102744
Volume 17, Issue 4, April 2023, 102744
There have been advancements in artificial intelligence (AI) and deep learning in the past decade. Recently, OpenAI Inc. has launched a new chatbot, called ChatGPT that interacts in a conversational way and its dialogue format makes is user friendly and fast. In this paper we aimed to explore the current position and the accuracy of currently available version of ChatGPT in relation to healthcare and medical research.
Kalyan Kumar Gangopadhyay a, 1 , Awadhesh Kumar Singh
doi : 10.1016/j.dsx.2023.102747
Volume 17, Issue 4, April 2023, 102747
Lobeglitazone (LGZ), a newly researched thiazolidinedione (TZD) thought to have lesser side effects compared with pioglitazone (PGZ), has been recently approved for the treatment of type 2 diabetes (T2D) in India. We aim to conduct an updated systematic review of LGZ to critically appraise its efficacy and safety in the context of PGZ.
Isabelle K. Mayne a, *, Henry M. Tyzack-Clark b , Andrew P. McGovern
doi : 10.1016/j.dsx.2023.102746
Volume 17, Issue 4, April 2023, 102746
We aimed to summarise the existing literature on insulin dose titration in gestation diabetes.
Seyed-Amir Tabatabaeizadeh a, *, Niayesh Tafazoli
doi : 10.1016/j.dsx.2023.102758
Volume 17, Issue 4, April 2023, 102758
Gestational diabetes mellitus is one of the important complications of pregnancy and is related to many adverse events. There is evidence that probiotics can be considered a preventive and therapeutic option in gestational diabetes mellitus. In this meta-analysis, we have focused on the effect of probiotic yogurt as a natural product on gestational diabetes mellitus.
Waseem Hassan a, *, Antonia Eliene Duarte b , Jean Paul Kamdem c , Joao B.T. da Rocha
doi : 10.1016/j.dsx.2023.102760
Volume 17, Issue 4, April 2023, 102760
Iyanu V. Olateju a , Taiwo Opaleye-Enakhimion b , Jennifer E. Udeogu c , Jennifer Asuquo d , Kehinde T. Olaleye e , Egbebalakhamen Osa f , Adeolu Funso Oladunjoye g, * a Department of Medicine, MedStar Harbor Hospital, Baltimore, MD, USA
doi : 10.1016/j.dsx.2023.102759
Volume 17, Issue 4, April 2023, 102759
Armia Ahmadi-Hadad
doi : 10.1016/j.dsx.2023.102755
Volume 17, Issue 4, April 2023, 102755
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟